Fosamprenavir calcium

This classification denotes a protease inhibitor C25H34N3O9PS.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ID1GU2627N, chemically known as (3s)-tetrahydro-3-furyl ((.alpha.s)-.alpha.-((1r)-1-hydroxy-2-(n1-isobutylsulfanilamido)ethyl)phenethyl)carbamate, calcium phosphate (ester) (1:1), but more generally known as fosamprenavir calcium, which bears US NIH Compound Identifier 131535. European Medicines Agency schedules Fosamprenavir calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20055. Most nations, for tariff and trade purposes, schedule fosamprenavir calcium under HS 29350090 and SITC 51580. As of Q4 2014, FOSAMPRENAVIR CALCIUM remains US FDA's Preferred Term for this commodity. Fosamprenavir calcium bears US NLM identifiers UMLS ID C1320129 and NCI Concept Code C61771. SMILES: CC(C)CN(C[C@H]([C@H](CC1CCCCC1)NC(=O)O[C@H]2CCOC2)OP(=O)([O-])[O-])S(=O)(=O)C3CCC(CC3)N.[CA+2].